photo of

Details

Role Group Leader / Honorary Fellow Manager
Research area Clinical Sciences

Contact

Available for student supervision
I am a consultant clinical geneticist and clinician scientist with a research focus on human genetics. In 2016 I was appointed to the position of inaugural Pamela and Lorenzo Galli Chair in Developmental Medicine, with a specific research and clinical focus on the causes of intellectual and physical disability.

I completed RACP training in paediatrics and clinical genetics in 2000 before undertaking PhD studies in chromosome biology completed in 2004. Since 2005 I have worked as a consultant clinical geneticist at Victorian Clinical Genetics Services (VCGS) and as a Research Group leader at Murdoch Children’s Research Institute (MCRI). From 2009 to 2016 I was Director of Victorian Clinical Genetics Services.
I am a consultant clinical geneticist and clinician scientist with a research focus on human genetics. In 2016 I was appointed to the position of inaugural Pamela and Lorenzo Galli Chair in Developmental Medicine, with a specific research and...
I am a consultant clinical geneticist and clinician scientist with a research focus on human genetics. In 2016 I was appointed to the position of inaugural Pamela and Lorenzo Galli Chair in Developmental Medicine, with a specific research and clinical focus on the causes of intellectual and physical disability.

I completed RACP training in paediatrics and clinical genetics in 2000 before undertaking PhD studies in chromosome biology completed in 2004. Since 2005 I have worked as a consultant clinical geneticist at Victorian Clinical Genetics Services (VCGS) and as a Research Group leader at Murdoch Children’s Research Institute (MCRI). From 2009 to 2016 I was Director of Victorian Clinical Genetics Services.

Top Publications

  • McClaren, BJ, Aitken, M, Massie, J, Amor, D, Ukoumunne, OC, Metcalfe, SA. Cascade carrier testing after a child is diagnosed with cystic fibrosis through newborn screening: investigating why most relatives do not have testing. Genetics in Medicine 15(7) : 533 -540 2013
    view publication
  • Heath, JA, Ng, J, Beshay, V, Coleman, L, Lo, P, Amor, DJ. Anaplastic oligodendroglioma in an adolescent with Lynch syndrome. Pediatric Blood & Cancer 60(6) : e13 -e15 2013
    view publication
  • Risheg, H, Pasion, R, Sacharow, S, Proud, V, Immken, L, Schwartz, S, Tepperberg, JH, Papenhausen, P, Tan, TY, Andrieux, J, et al. Clinical Comparison of Overlapping Deletions of 19p13.3. American Journal of Medical Genetics Part A 161(5) : 1110 -1116 2013
    view publication
  • Godler, DE, Inaba, Y, Shi, EZ, Skinner, C, Bui, QM, Francis, D, Amor, DJ, Hopper, JL, Loesch, DZ, Hagerman, RJ, et al. Relationships between age and epi-genotype of the FMR1 exon 1/intron 1 boundary are consistent with non-random X-chromosome inactivation in FM individuals, with the selection for the unmethylated state being most significant between birth and puberty. Human Molecular Genetics 22(8) : 1516 -1524 2013
    view publication
  • Inaba, Y, Herlihy, AS, Schwartz, CE, Skinner, C, Bui, QM, Cobb, J, Shi, EZ, Francis, D, Arvaj, A, Amor, DJ, et al. Fragile X–related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study. Genetics in Medicine 15(4) : 290 -298 2013
    view publication